Real-world drug survival of interclass versus intraclass switching in psoriasis patients with previous secondary IL-17 inhibitor failure

Published: 12 March 2026| Version 1 | DOI: 10.17632/8wkf73ccmv.1
Contributor:
Ioannis-Alexios Koumprentziotis

Description

Supplementary table 1: Univariable and multivariable Cox regression analysis for drug discontinuation after switching.

Files

Categories

Dermatology, Psoriasis

Licence